RGEN Repligen Inc.: Bozor kapitallashuvining balans qiymatiga nisbati

Repligen Corp (RGEN) kompaniyasining rasmiy ramzlari

Repligen Corporation (RGEN) biofarmatsevtika uchun analitik asboblar va tozalash tizimlari sotuvi orqali daromad keltiradi. Kompaniya sezilarli ilmiy salohiyatga ega bo'lib, hujayralarni yetishtirish usullarini takomillashtirish uchun tadqiqot va ishlanmalarga ( R&D ) mablag' ajratmoqda. Joriy ko'rsatkich 4.79 darajasida turibdi, shu bilan birga, zaxiralarni kamaytirishdan keyin sarflanadigan materiallarga bo'lgan talabning tiklanishi o'zining ilk natijalarini bermoqda. Ushbu grafik Repligen Corporation (RGEN) uchun narx harakatini aks ettiradi.

Repligen Inc. (RGEN): Kapitallashuvning balans qiymatiga nisbati 04.07.2022dan 27.10.2026gacha

RGEN (Repligen Corp): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Narx grafigi Repligen Corporation|RGEN - Investitsiya uylarining umumiy prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Repligen Corp.|RGEN - Biznes qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Repligen|RGEN - Buxgalteriya kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati repligen.com|RGEN - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Repligen Corporation|RGEN - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Repligen Corp.|RGEN - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Repligen Corp.
Fundamental baholash:RGEN Repligen Corporation
Repligen Corp original mahsuloti

Ushbu koeffitsiyent barcha aksiyalarning bozor qiymatining kompaniyaning sof aktivlariga nisbati sifatida hisoblanadi va investorlarning joriy aktivlardan ko'ra kelajakdagi o'sish uchun to'laydigan premiumini aks ettiradi. Repligen Corporation (RGEN) kompaniyasining bozor qiymatining buxgalteriya qiymatiga nisbati grafigini tahlil qilish orqali, nisbatda tor doiradagi bioprotsessing texnologiyalarining yuqori baholanishi global gen terapiyasi bozori uchun ularning muhim ahamiyati bilan qanchalik asoslanganini baholash mumkin.

Toʻgʻridan-toʻgʻri raqobatchilar

Bozor qiymatining balans qiymatiga nisbati Tempus Labs|qiagen.com (QGEN) - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Ionis (IONS)|Kapitallashuvning balans qiymatiga nisbati RNA|Bozor qiymatining balans qiymatiga nisbati CRISPR Therapeutics Corp CRSP|Kapitallashuvning balans qiymatiga nisbati GeneDx Corp (WGS)|Bozor kapitallashuvining balans qiymatiga nisbati RARE (Ultragenyx Pharmaceutical)|beamtx.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Sarepta (SRPT)|TWST - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati TXG|NTLA (Intellia Corp) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Stoke Therapeutics STOK|Sof aktivlarga nisbatan bozor kapitallashuvi BLFS|Bozor qiymatining balans qiymatiga nisbati Wave Life Sciences Ltd. (WVE)|Bozor qiymatining balans qiymatiga nisbati Maze Therapeutics, Inc. (MAZE)|Bozor kapitallashuvining balans qiymatiga nisbati SION|Balans qiymatiga nisbatan bozor kapitallashuvi Prime Medicine Bio PRME|Bozor kapitallashuvining balans qiymatiga nisbati TSHA|QURE - Bozor qiymatining xususiy kapitalga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati MGTX|RGNX (REGENXBIO Inc) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Solid Bio (SLDB)|Kapitallashuvning balans qiymatiga nisbati Ocugen Pharma (OCGN)|Pacific Biosciences (PACB) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati benitec.com (BNTC)|Design Therapeutics, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Rocket Pharma - Kapitallashuvning sof aktivlarga nisbati|FDMT (4D Molecular Therapeutics Inc) - Bozor qiymatining balans qiymatiga nisbati|LXEO: Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati korrobio.com KRRO|EDIT (editasmedicine.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Silence Therapeutics plc SLN|Sof aktivlarga nisbatan bozor kapitallashuvi PRQR|Codexis, Inc. - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti SGMO (Sangamo BioSciences)|Bozor qiymatining balans qiymatiga nisbati Nautilus Bio|Balans qiymatiga nisbatan bozor qiymati metagenomi.co MGX|Precision BioSciences - Bozor kapitallashuvining balans qiymatiga nisbati|Generation Bio Co. (GBIO) - Bozor kapitallashuvining balans qiymatiga nisbati|BOLD - Kapitallashuvning sof aktivlarga nisbati|Exicure (XCUR) - Bozor kapitallashuvining balans qiymatiga multiplikatori|IMNN: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi PHIO|Mustang Bio, Inc. - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti RNAZ (transcodetherapeutics.com)|BNGO - Bozor qiymatining balans qiymatiga nisbati|Applied DNA Corp - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati bluebird bio, Inc. (BLUE)|IPA - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati OMGA (Omega Therapeutics, Inc.)|Singular Genomics Systems, Inc. (OMIC) - Bozor qiymatining xususiy kapitalga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati RGLS (Regulus Therapeutics Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti SYRS|Bozor qiymatining balans qiymatiga nisbati Telesis Bio, Inc. TBIO|Kapitallashuvning balans qiymatiga nisbati traconpharma.com (TCON)|UBX - Bozor kapitallashuvining balans qiymatiga nisbati